Accessibility Menu
Bespoke Extracts logo

Bespoke Extracts(OTC) BSPK

Current Price$0.00
Market Cap$7.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2011)-100%
5 Year-100%
1 Year-100%
1 Month-100%
Bespoke Extracts last closing stock price
MetricPriceDate
Last closeUSD 0.002026-07-23
Bespoke Extracts stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-99.42%USD 0.122026-07-16
1 month-99.59%USD 0.172026-06-23
3 month-99.69%USD 0.232026-04-21
Year to date-99.65%USD 0.202025-12-22
1 year-99.62%USD 0.192025-07-23
3 year-99.23%USD 0.092023-07-24
5 year-99.92%USD 0.862021-07-23
Since inception-100%USD 3,746.252011-11-17

Bespoke Extracts Financials at a Glance

Market Cap

$7.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.42M

Net Income (TTM)

-$730.56K

EPS (TTM)

-$0.07

P/E Ratio

-0.01

Dividend

$0.00

Beta (Volatility)

12.67 (High)

Price

$0.00

Volume

659

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.35

Estimated Earnings Date

Apr 20, 2026

BSPK News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bespoke Extracts

Bespoke Extracts makes hemp and marijuana products for wellness and recreation. Its CBD lotions and pre-rolled joints target adults seeking relief or relaxation. The company sells online and through Colorado dispensaries, focusing on regulated markets.

What’s in the Jar? Products and Services

  • CBD Formulations: Hemp-derived products like lotions, balms, and manuka honey blends for adults seeking wellness support. (Revenue share not disclosed)
  • Capsules and Gummies: Oral CBD products for users preferring easy, measured doses. (Revenue share not disclosed)
  • Pre-Rolled Joints: Marijuana joints sold in Colorado dispensaries, aimed at recreational and medical users. (Major revenue driver; exact share not disclosed)
  • Joint Production Services: Manufacturing pre-rolled joints for third-party brands in Colorado. (Revenue share not disclosed)
  • Fresh Joint Line: New pre-rolled joint products under "The Joint Company" brand, launched in 2025. (Revenue share not disclosed)

Growth and Expansion: Rolling with the Changes

  • Acquired WonderLeaf assets in December 2021, adding marijuana manufacturing and equipment.
  • Rebranded Colorado products as "The Joint Company" in January 2025.
  • Launched new pre-rolled joint products and expanded joint production services in 2025.
  • Secured a facility lease in Aurora, Colorado, with an option to purchase for $600,000.

What Makes Bespoke Extracts Stand Out

Bespoke Extracts focuses on Colorado’s regulated cannabis market, combining direct sales and wholesale distribution. The company vertically integrates manufacturing and product development, aiming for operational efficiency. Its rebranding and expanded product lines target both consumers and third-party brands.

Five Things You Need to Know

  • Q2 2023 revenue was $188,247, up 54,306.6% from Q2 2022.
  • Gross profit in Q2 2023 was $71,036, reversing a loss in Q2 2022.
  • Operating loss improved to $-467,502 in Q2 2023, up 53.8% year-on-year.
  • All sales are in Colorado; no international revenue reported as of June 2025.
  • Cash at June 30, 2025, was $1,363, with a working capital deficit of $1.33 million.

Bottom Line

Bespoke Extracts has shifted from CBD to marijuana products, focusing on Colorado’s market. The company faces financial challenges but continues to adapt its product mix and operations.

AI Generated • Apr 16, 2026

Industry

Pharmaceuticals

Employees

8

CEO

Michael R. Feinsod

Headquarters

Aurora, CO 80205, US

BSPK Financials

Key Financial Metrics (TTM)

Gross Margin

48.36%

Operating Margin

-41.12%

Net Income Margin

-48.47%

Return on Equity

21.84%

Return on Capital

N/A

Return on Assets

-183.95%

Earnings Yield

-100.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$7.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

11.25M

Volume

659

Avg. Volume

1.74K

Financials (TTM)

Gross Profit

$671.70K

Operating Income

-$640.30K

EBITDA

-$564.89K

Operating Cash Flow

-$259.70K

Capital Expenditure

-$13.65K

Free Cash Flow

-$259.70K

Cash & ST Invst.

$16.74K

Total Debt

$1.50M

Bespoke Extracts Performance Analysis

Bespoke Extracts annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 4,646-86.9%
20222022-12-31USD 3,407-26.7%
20232023-12-31USD 785,45322954.1%
20242024-12-31USD 1,117,45242.3%
Bespoke Extracts sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31N/A
Q12025-03-31-12.7%
Q22025-06-3048.4%
Q32025-09-3019.8%
Bespoke Extracts annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD -0.204776.2%
20222022-12-31USD -0.44114.5%
20232023-12-31USD -0.15-66.8%
20242024-12-31USD -0.10-32.4%
Bespoke Extracts sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31N/A
Q12025-03-31-39.3%
Q22025-06-3021.4%
Q32025-09-3062.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$467.95K

+148.6%

Gross Profit

$234.18K

+229.7%

Gross Margin

50.04%

N/A

Market Cap

$7.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$3.95K

N/A

Employees

2

N/A

Net Income

-$78.09K

+83.2%

EBITDA

-$40.33K

+91.0%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Total Cash

$16.74K

+759.9%

Total Debt

$1.50M

+32.2%

Accounts Receivable

$103.53K

+144.7%

Inventory

$63.66K

+50.3%

Long Term Debt

$1.02M

-1.4%

Short Term Debt

$479.71K

+378.4%

Return on Assets

-1.84%

N/A

Return on Invested Capital

29.24%

N/A

Free Cash Flow

-$19.62K

+90.0%

Operating Cash Flow

-$19.62K

+90.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
KAYSKaya Holdings, Inc.
$0.00+50.00%
KHRNFKhiron Life Sciences Corp.
$0.00+0.00%
KOANResonate Blends, Inc.
$0.00+0.00%
HEMPHemp, Inc
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$92.32-0.08%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%
SOFISoFi Technologies
$16.46-0.01%

Questions About BSPK

What is the current price of Bespoke Extracts?

Bespoke Extracts is trading at $0.00 per share.

What is the 52-week range for Bespoke Extracts?

Over the past 52 weeks, Bespoke Extracts has traded between $0.00 and $0.35.

How much debt does Bespoke Extracts have?

As of the most recent reporting period, Bespoke Extracts reported total debt of $1.50M.

How much cash does Bespoke Extracts have on hand?

Bespoke Extracts reported $16.74K in cash and cash equivalents in its most recent financial results.

What is Bespoke Extracts’s dividend yield?

Bespoke Extracts does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.